Clinical and economic impact of ventricular assist device infections: a real-world claims analysis

References

• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). developed with the special contribution of the heart failure association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975. doi: 10.1002/ejhf.592.
   PubMed Web of Science ®Google Scholar
• Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357(9):885–896. doi: 10.1056/NEJMoa067758.
   PubMed Web of Science ®Google Scholar
• Phadke VK, Pouch SM. Contemporary management strategies in VAD infection. Curr Heart Fail Rep. 2020;17(4):85–96. doi: 10.1007/s11897-020-00459-x.
   PubMed Web of Science ®Google Scholar
• O’Horo JC, Abu Saleh OM, Stulak JM, et al. Left ventricular assist device infections: a systematic review. Asaio J. 2018;64(3):287–294. doi: 10.1097/MAT.0000000000000684.
   PubMed Web of Science ®Google Scholar
• John R, Aaronson KD, Pae WE, et al. Drive-line infections and sepsis in patients receiving the HVAD system as a left ventricular assist device. J Heart Lung Transplant. 2014;33(10):1066–1073. doi: 10.1016/j.healun.2014.05.010.
   PubMed Web of Science ®Google Scholar
• Akhter SA, Badami A, Murray M, et al. Hospital readmissions after continuous-flow left ventricular assist device implantation: incidence, causes, and cost analysis. Ann Thorac Surg. 2015;100(3):884–889. doi: 10.1016/j.athoracsur.2015.03.010.
   PubMed Web of Science ®Google Scholar
• Pavlovic NV, Randell T, Madeira T, et al. Risk of left ventricular assist device driveline infection: a systematic literature review. Heart Lung. 2019;48(2):90–104. doi: 10.1016/j.hrtlng.2018.11.002.
   PubMed Web of Science ®Google Scholar
• Mahr C, McGee E, Jr., Cheung A, et al. Cost-effectiveness of thoracotomy approach for the implantation of a centrifugal left ventricular assist device. Asaio J. 2020;66(8):855–861. doi: 10.1097/MAT.0000000000001209.
   PubMed Web of Science ®Google Scholar
• Shah P, Birk SE, Cooper LB, et al. Stroke and death risk in ventricular assist device patients varies by ISHLT infection category: an INTERMACS analysis. J Heart Lung Transplant. 2019;38(7):721–730. doi: 10.1016/j.healun.2019.02.006.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014;12(12):1500–1524. doi: 10.1016/j.ijsu.2014.07.014.
   PubMed Web of Science ®Google Scholar
• Motheral B, Brooks J, Clark MA, et al. A checklist for retrospective database studies–report of the ISPOR task force on retrospective databases. Value Health. 2003;6(2):90–97. doi: 10.1046/j.1524-4733.2003.00242.x.
   PubMed Web of Science ®Google Scholar
• Eby EL, Bengtson LGS, Johnson MP, et al. Economic impact of cardiac implantable electronic device infections: cost analysis at one year in a large U.S. health insurer. J Med Econ. 2020;23(7):698–705. doi: 10.1080/13696998.2020.1751649.
   PubMed Web of Science ®Google Scholar
• Hannan MM, Husain S, Mattner F, et al. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant. 2011;30(4):375–384. doi: 10.1016/j.healun.2011.01.717.
   PubMed Web of Science ®Google Scholar
• U.S. Bureau of Labor Statistics. All Urban US city average cpi for medical care services 2012-2022);https://www.bls.gov/data/#prices.
   Google Scholar
• Gordon RJ, Weinberg AD, Pagani FD, et al. Prospective, multicenter study of ventricular assist device infections. Circulation. 2013;127(6):691–702. doi: 10.1161/CIRCULATIONAHA.112.128132.
   PubMed Web of Science ®Google Scholar
• Juraszek A, Smólski M, Kołsut P, et al. Prevalence and management of driveline infections in mechanical circulatory support - a single center analysis. J Cardiothorac Surg. 2021;16(1):216. doi: 10.1186/s13019-021-01589-6.
   PubMed Web of Science ®Google Scholar
• Patel CB, Blue L, Cagliostro B, et al. Left ventricular assist systems and infection-related outcomes: a comprehensive analysis of the MOMENTUM 3 trial. J Heart Lung Transplant. 2020;39(8):774–781. doi: 10.1016/j.healun.2020.03.002.
   PubMed Web of Science ®Google Scholar
• Freed M, Fuglesten Biniek J, Damico A, et al. Medicare advantage in 2021: enrollment update and key trends. https://wwwkfforg/medicare/issue-brief/medicare-advantage-in-2021-enrollment-update-and-key-trends/.
   Google Scholar
• Modi K, Pannu AK, Modi RJ, et al. Utilization of left ventricular assist device for congestive heart failure: inputs on demographic and hospital characterization from nationwide inpatient sample. Cureus. 2021;13(7):e16094. doi: 10.7759/cureus.16094.
   PubMed Web of Science ®Google Scholar
• Birnie DH, Wang J, Alings M, et al. Risk factors for infections involving cardiac implanted electronic devices. J Am Coll Cardiol. 2019;74(23):2845–2854. doi: 10.1016/j.jacc.2019.09.060.
   PubMed Web of Science ®Google Scholar
• Ahmed FZ, Blomström-Lundqvist C, Bloom H, et al. Use of healthcare claims to validate the prevention of arrhythmia device infection trial cardiac implantable electronic device infection risk score. Europace. 2021;23(9):1446–1455. doi: 10.1093/europace/euab028.
   PubMed Web of Science ®Google Scholar
• Olsen T, Jørgensen OD, Nielsen JC, et al. Incidence of device-related infection in 97 750 patients: clinical data fromthe complete danish device-cohort (1982–2018). Eur Heart J. 2019;40(23):1862–1869. doi: 10.1093/eurheartj/ehz316.
   PubMed Web of Science ®Google Scholar